abstract |
The present invention relates to a low molecular weight apoE mimetic suitable for the manufacture of a medicament for the treatment of autoimmunity, inflammation or neurodegenerative diseases: (X) a -L- (X) b (Formula I) wherein X is , A chemical moiety that is positively charged (potentially different) at physiological pH, a and b are independently numbers from 3 to 6; and L is a linker. |